Uniphos Enterprises Limited
Uniphos Enterprises Limited Fundamental Analysis
Uniphos Enterprises Limited (UNIENTER.NS) shows weak financial fundamentals with a PE ratio of 33.34, profit margin of 25.19%, and ROE of 0.73%. The company generates $0.8B in annual revenue with weak year-over-year growth of 1.20%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 65.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze UNIENTER.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakUNIENTER.NS struggles to generate sufficient returns from assets.
Valuation Score
WeakUNIENTER.NS trades at a premium to fair value.
Growth Score
WeakUNIENTER.NS faces weak or negative growth trends.
Financial Health Score
ExcellentUNIENTER.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateUNIENTER.NS maintains healthy but balanced margins.
Key Financial Metrics
Is UNIENTER.NS Expensive or Cheap?
P/E Ratio
UNIENTER.NS trades at 33.34 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, UNIENTER.NS's PEG of 7.56 indicates potential overvaluation.
Price to Book
The market values Uniphos Enterprises Limited at 0.23 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 32.84 times EBITDA. This signals the market has high growth expectations.
How Well Does UNIENTER.NS Make Money?
Net Profit Margin
For every $100 in sales, Uniphos Enterprises Limited keeps $25.19 as profit after all expenses.
Operating Margin
Core operations generate -6.59 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.73 in profit for every $100 of shareholder equity.
ROA
Uniphos Enterprises Limited generates $0.67 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Uniphos Enterprises Limited generates limited operating cash flow of $-20.75M, signaling weaker underlying cash strength.
Free Cash Flow
Uniphos Enterprises Limited generates weak or negative free cash flow of $-20.75M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.30 in free cash annually.
FCF Yield
UNIENTER.NS converts -0.31% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
33.34
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
7.56
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.23
vs 25 benchmark
P/S Ratio
Price to sales ratio
8.40
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
9.06
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.007
vs 25 benchmark
ROA
Return on assets percentage
0.007
vs 25 benchmark
ROCE
Return on capital employed
-0.00
vs 25 benchmark
How UNIENTER.NS Stacks Against Its Sector Peers
| Metric | UNIENTER.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 33.34 | 23.91 | Worse (Expensive) |
| ROE | 0.73% | 887.00% | Weak |
| Net Margin | 25.19% | -114589.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.55 | Strong (Low Leverage) |
| Current Ratio | 9.06 | 5.05 | Strong Liquidity |
| ROA | 0.67% | -6361.00% (disorted) | Weak |
UNIENTER.NS outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Uniphos Enterprises Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
49562.82%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
-98.60%
Industry Style: Cyclical, Commodity, Value
DecliningFCF CAGR
-30.26%
Industry Style: Cyclical, Commodity, Value
Declining